Countries citing papers authored by Masayuki Mikage
Since
Specialization
Citations
This map shows the geographic impact of Masayuki Mikage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Mikage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Mikage more than expected).
This network shows the impact of papers produced by Masayuki Mikage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Mikage. The network helps show where Masayuki Mikage may publish in the future.
Co-authorship network of co-authors of Masayuki Mikage
This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Mikage.
A scholar is included among the top collaborators of Masayuki Mikage based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Masayuki Mikage. Masayuki Mikage is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Mikage, Masayuki & Nobuko Kakiuchi. (2005). The recent situation of the resources of Chinese crude drug Ma-huang, Ephedrae Herba. 22(1). 61–69.4 indexed citations
10.
Mikage, Masayuki, et al.. (2004). Studies of Ephedra Plants in Asia. Part 2 : On the Current Situation of the Cultivation of Ephedra Plants in China. Natural medicines = 生薬學雜誌. 58(6). 312–320.2 indexed citations
11.
Mikage, Masayuki, et al.. (2003). Evaluation of the Crude Drugs by means of Colorimeter. Part 5. : Correlation between the Color and Curcumin Content of Turmeric. Natural medicines = 生薬學雜誌. 57(6). 246–249.3 indexed citations
12.
Yoshida, Ai, et al.. (2001). Studies of Rhei Rhizoma(Da-huang; Dai-o) (II) - The reason Da-huang is processed by heating.. 55(6). 294–299.1 indexed citations
13.
Komatsu, Katsuko, Masayuki Mikage, & T. Namba. (1990). Pharmacognostical studies on the Chinese crude drug 'Fu pen zi' (6) on botanical origin of 'Fu pen zi' from Korea (III). 44(4). 255–264.1 indexed citations
14.
Komatsu, Katsuko, Masayuki Mikage, & Tsuneo Namba. (1990). Pharmacognostical Studies on the Chinese Crude Drug"Fu pen zi"(覆盆子)-6-On Botanical Origin of"Fu pen zi"from Korea-3-. 44(4). 255–264.1 indexed citations
15.
Mikage, Masayuki, et al.. (1989). Screening of crude drugs used in Bangladesh for nematocidal activity on the larva of Toxocara canis. 45(3). 206–214.6 indexed citations
16.
Mikage, Masayuki, et al.. (1987). Studies on the Nepalese Crude Drugs (VII) : On the Variation in the Morphological Appearances and the Alkaloid Contents of the Herbal Stem of Ephedra gerardiana WALL. According to the Differences of Habitats. 41(3). 209–214.4 indexed citations
17.
Namba, Tsuneo, et al.. (1984). Pharmacognostical Study on the Crude Drug "In Jin Go" from Korea. 38(3). 264–275.1 indexed citations
18.
Mikage, Masayuki & Tsuneo Namba. (1983). Pharmacognostical Studies on the Clematis Plants and Related Crude Drugs-2-On the Botanical Origin of "Wei-ling-xian"(威霊仙) from Taiwan and Liang-guang.. 37(4). 317–324.
19.
Mikage, Masayuki & Tsuneo Namba. (1983). Pharmacognostical Studies on the Clematis Plants and Related Crude Drugs-3-On "Wei-ling-xian"(威霊仙) from Korean Peninsula. 37(4). 325–333.
20.
Namba, Tsuneo & Masayuki Mikage. (1983). Pharmacognostical Studies on the Clematis Plants and Related Crude Drugs-1-Histological Studies on the Roots of Clematis terniflora DC.var.robusta(CARR.)TAMURA and "Wei-ling-xian"(威霊仙) from Japan. 37(4). 307–316.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.